Clinical efficacy of convalescent plasma for treatment of COVID-19 infections: Results of a multicenter clinical study
H Abolghasemi, P Eshghi, AM Cheraghali… - … and Apheresis Science, 2020 - Elsevier
Since Dec. 2019 the new coronavirus (SARS-CoV-2) has infected millions and claimed life
of several hundred thousand worldwide. However, so far no approved vaccine or drug
therapy is available for treatment of virus infection. Convalescent plasma has been
considered a potential modality for COVID-19 infection. One hundred eighty-nine COVID-19
positive patients including 115 patients in plasma therapy group and 74 patients in control
group, registered in the hospitals with confirmed COVID-19 infection, entered this multi …
of several hundred thousand worldwide. However, so far no approved vaccine or drug
therapy is available for treatment of virus infection. Convalescent plasma has been
considered a potential modality for COVID-19 infection. One hundred eighty-nine COVID-19
positive patients including 115 patients in plasma therapy group and 74 patients in control
group, registered in the hospitals with confirmed COVID-19 infection, entered this multi …